Validation Study of the Korean Version of the EORTC QLQ-HDC29
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01208532|
Recruitment Status : Completed
First Posted : September 24, 2010
Last Update Posted : April 23, 2015
|Condition or disease|
|Quality of Life After Stem Cell Transplantation|
|Study Type :||Observational|
|Actual Enrollment :||226 participants|
|Official Title:||Quality of Life in Patients With Stem Cell Transplant After High Dose Chemotherapy: Validation Study of the Korean Version of the EORTC QLQ-HDC29|
|Study Start Date :||September 2010|
|Actual Primary Completion Date :||December 2013|
|Actual Study Completion Date :||December 2013|
- Reliability and validity of the Korean version of the EORTC HDC-29 [ Time Frame: at the patient's hospitalization (before the SCT) and the outpatient clinic (three, six, and 12 months after their SCT) ]
Relaibility; Cronbach's alpha coefficient is used to evaluate the internal consistency.
Validity; Persons's correlation coefficient is used to examine the correlation between similar dimensions of the different questionnaires.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01208532
|Korea, Republic of|
|Seoul National University Hospital|
|Seoul, Korea, Republic of|
|Principal Investigator:||Sung-Soo Yoon, MD, PhD||Seoul National University Hospital|
|Principal Investigator:||Jung Mi Oh, Pharm.D.||College of Pharmacy, Seoul National University|